Determinants of inappropriate drug use in developing nations Newsletter Article 08 February 2013 Pages: 3 - 3
Placing sumatriptan on HMO formulary improves outcomes Newsletter Article 08 February 2013 Pages: 3 - 3
Improved knowledge of costs required for better prescribing Newsletter Article 08 February 2013 Pages: 5 - 5
Economic burden of RA - absolute and incremental perspectives Newsletter Article 08 February 2013 Pages: 5 - 5
Cefaclor most favoured second-line agent for otitis media Newsletter Article 08 February 2013 Pages: 6 - 6
Simvastatin cost per life-year saved favourable in CAD Newsletter Article 08 February 2013 Pages: 6 - 7
Prescribing costs of GP fundholders vs nonfundholders in UK Newsletter Article 08 February 2013 Pages: 7 - 7
Comprehensive claims analysis tool for managed-care industry Newsletter Article 08 February 2013 Pages: 7 - 7
HIV combination therapies gain subsidy in New Zealand Newsletter Article 08 February 2013 Pages: 8 - 8